These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32463767)

  • 1. Evolution of the Pharmacy Benefit Manager/Community Pharmacy Relationship: An Opportunity for Success.
    Taddei-Allen P
    J Manag Care Spec Pharm; 2020 Jun; 26(6):708-710. PubMed ID: 32463767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Sleeping Giant: Community Pharmacy's Potential Is Unrivaled.
    Trygstad T
    J Manag Care Spec Pharm; 2020 Jun; 26(6):705-708. PubMed ID: 32463770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction: Pharmacy Reimbursement.
    Greenwood BC
    J Manag Care Spec Pharm; 2020 Jun; 26(6):702. PubMed ID: 32463773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To Reform Pharmacy Reimbursement Begin with the Basics.
    Rupp MT
    J Manag Care Spec Pharm; 2020 Jun; 26(6):713-715. PubMed ID: 32463772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Employer and Plan Sponsor Views on Pharmacy Reimbursement.
    Stull M; Gupton C
    J Manag Care Spec Pharm; 2020 Jun; 26(6):710-712. PubMed ID: 32463776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacy practice in China: past, present and future.
    Fang Y; Yang S; Zhou S; Jiang M; Liu J
    Int J Clin Pharm; 2013 Aug; 35(4):520-8. PubMed ID: 23661172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of community pharmacies in North West England: an observational study.
    Mackridge AJ; Stokes EC; Gray NJ
    Int J Pharm Pract; 2017 Apr; 25(2):172-175. PubMed ID: 27198475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paradox of pharmacy: A profession's house divided.
    Brown D
    J Am Pharm Assoc (2003); 2012; 52(6):e139-43. PubMed ID: 23143300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Medication Adherence Among Pharmacies Participating in a North Carolina Enhanced Services Network.
    Urick BY; Bhosle M; Farley JF
    J Manag Care Spec Pharm; 2020 Jun; 26(6):718-722. PubMed ID: 32463769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apocalypse Now?
    Rupp MT
    Ann Pharmacother; 2017 Oct; 51(10):921-922. PubMed ID: 28608718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corporate control and professional prerogative: an unresolved tension for pharmacists.
    Clark BE
    Res Social Adm Pharm; 2009 Dec; 5(4):299-301. PubMed ID: 19962672
    [No Abstract]   [Full Text] [Related]  

  • 12. Community pharmacy in the United Arab Emirates: characteristics and workforce issues.
    Hasan S; Sulieman H; Chapman C; Stewart K; Kong DC
    Int J Pharm Pract; 2011 Dec; 19(6):392-9. PubMed ID: 22060234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating influences on current community pharmacy practice at micro, meso, and macro levels.
    Hermansyah A; Sainsbury E; Krass I
    Res Social Adm Pharm; 2017; 13(4):727-737. PubMed ID: 27530306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial Sustainability of an Oregon Rural Health, Primary Care, and Pharmacist-Run Comprehensive Medication Management Program Through Direct Medical Billing.
    Hoover ND; Turner RB; Sampson J; Pye T; Hotan T
    J Manag Care Spec Pharm; 2020 Jan; 26(1):30-34. PubMed ID: 31880232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health champions in South London: evaluation of training, and impact on public health.
    Micallef R; Grewal JS; Khan S; Wells J; Kayyali R
    Int J Pharm Pract; 2019 Feb; 27(1):71-79. PubMed ID: 29949210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruptive innovation in community pharmacy - Impact of automation on the pharmacist workforce.
    Spinks J; Jackson J; Kirkpatrick CM; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(2):394-397. PubMed ID: 27283243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom.
    Bush J; Langley CA; Wilson KA
    Res Social Adm Pharm; 2009 Dec; 5(4):305-18. PubMed ID: 19962674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality improvement of community pharmacy services: a prioritisation exercise.
    Newlands RS; Power A; Young L; Watson M
    Int J Pharm Pract; 2018 Feb; 26(1):39-48. PubMed ID: 28349646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The organisation and development of primary care pharmacy in the United Kingdom.
    Silcock J; Raynor DK; Petty D
    Health Policy; 2004 Feb; 67(2):207-14. PubMed ID: 14720638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.